Invention Grant
- Patent Title: Alkylated piperazine compounds
-
Application No.: US14246471Application Date: 2014-04-07
-
Publication No.: US08946213B2Publication Date: 2015-02-03
- Inventor: James John Crawford , Wendy B. Young
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Genentech, Inc.
- Agent Alex Andrus
- Main IPC: A61K31/5386
- IPC: A61K31/5386 ; A61K31/496 ; A61K31/4985 ; A61K31/5025 ; A61K45/06 ; C07D498/08 ; C07D471/04 ; C07D495/04 ; C07D519/00 ; C07D471/14 ; C07D487/04

Abstract:
Alkylated piperazine compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating cancer mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of cancer in mammalian cells, or associated pathological conditions, are disclosed.
Public/Granted literature
- US20140221365A1 ALKYLATED PIPERAZINE COMPOUNDS Public/Granted day:2014-08-07
Information query
IPC分类: